Tumor-infiltrating CD4+ CD25+ FOXP3+ Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma
Open Access
- 9 May 2025
- journal article
- research article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 20 (1) , 1-9
Abstract
Regulatory T cells (Tregs) play a significant role in immune evasion within the tumor microenvironment (TME). Nasopharyngeal carcinoma (NPC) is strongly associated with Epstein-Barr virus (EBV) infection. Previous studies have shown that EBV can suppress immune activity. The relationship between plasma EBV DNA levels and Treg infiltration in NPC remains to be elucidated. Some studies have shown that FOXP3, a Treg marker, is a favorable prognostic factor in NPC. However, relying solely on FOXP3 for Treg identification may be unreliable due to its expression in other cell types. Therefore, this study investigated the impact of tumor-infiltrating Tregs identified by CD4, CD25, and FOXP3 triple markers in NPC and the relationship between these Tregs and EBV infection. In this study, 103 NPC patients were included. All tumor slides were stained using multi-immunofluorescence with CD4, CD25, and FOXP3. HALO software was used to analyze whole-slide images. The correlation between two factors was assessed using Spearman analysis. The prognostic value of factors was evaluated using Kaplan-Meier curves and Cox regression. A significant positive correlation was observed between Treg infiltration in tumor tissues and plasma EBV DNA levels (r = 0.3428, p = 0.02). Higher Treg infiltration was significantly associated with poorer progression-free survival (PFS) (p = 0.03) and was an independent risk factor for NPC progression (p = 0.045). CD25 expression was positively correlated with plasma EBV DNA levels (r = 0.3229, p = 0.03). Furthermore, increased Treg infiltration was negatively correlated with peripheral CD8+ T cells (r=-0.3556, p = 0.006). The proportion of peripheral CD8+ T cells in patients with advanced-stage NPC was significantly lower compared to those with early stage (p = 0.02). This study identified tumor-infiltrating CD4+CD25+FOXP3+ Tregs as an independent negative prognostic factor for NPC progression and found higher Treg infiltration positively associated with plasma EBV DNA levels.Keywords
Funding Information
- Research Foundation of Education Bureau of Yunnan Province, China (2023Y0658)
- Yunnan Ten Thousand People Plan“Young Top Talents”Project (YNWR-QNBJ-2019-056)
- National Natural Science Foundation of China (82260485, 81960489)
This publication has 23 references indexed in Scilit:
- Epidemiology of nasopharyngeal carcinoma: current insights and future outlookCancer and Metastasis Reviews, 2024
- CD25: A potential tumor therapeutic targetInternational Journal of Cancer, 2022
- Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancerLaboratory Investigation, 2022
- Nasopharyngeal carcinoma: an evolving paradigmNature Reviews Clinical Oncology, 2021
- Mechanisms of Epstein‐Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinomaCancer Medicine, 2020
- Nasopharyngeal carcinomaThe Lancet, 2019
- Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinomaJournal of Clinical Pathology, 2017
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal CancerNew England Journal of Medicine, 2017
- High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironmentBritish Journal of Cancer, 2014
- Increase in circulating Foxp3+CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patientsBritish Journal of Cancer, 2007